L Lee Dupuis1,2, Joseph A Roscoe3, Ian Olver4, Matti Aapro5, Alexander Molassiotis6. 1. Department of Pharmacy and Research Institute, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada. lee.dupuis@sickkids.ca. 2. Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada. lee.dupuis@sickkids.ca. 3. Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA. 4. Sansom Institute for Health Research, University of South Australia, Adelaide, South Australia, Australia. 5. IMO Clinique de Genolier, Genolier, Switzerland. 6. School of Nursing, The Hong Kong Polytechnic University, Hong Kong, SAR, China.
Abstract
PURPOSE: We aimed to update the 2011 recommendations for the prevention and treatment of anticipatory nausea and vomiting in children and adults receiving chemotherapy. METHODS: The original systematic literature search was updated. Randomized studies were included in the evidence to support this guideline if they as follows: were primary studies published in a journal in full text (i.e., abstracts, letters, book chapters, and dissertations were excluded); published in English; evaluated an intervention for the prevention or treatment of anticipatory nausea and vomiting; reported the proportion of patients experiencing complete control of anticipatory nausea and vomiting consistently and; included at least ten participants per study arm for comparative studies and at least ten participants overall for noncomparative studies. RESULTS: Eighty-eight new citations were identified. Of these, nine were brought to full-text screening; none met inclusion criteria. The guideline panel continues to recommend that anticipatory nausea and vomiting are best prevented through optimization of acute and delayed phase chemotherapy-induced nausea and vomiting control. Benzodiazepines and behavioral therapies, in particular progressive muscle relaxation training, systematic desensitization and hypnosis, continue to be recommended for the treatment of anticipatory nausea and vomiting. CONCLUSIONS: No new information regarding interventions aimed at treating or preventing ANV that met criteria for inclusion in this systematic review was identified. The 2015 MASCC recommendations affirm the content of the 2009 MASCC recommendations for the prevention and treatment of anticipatory nausea and vomiting.
PURPOSE: We aimed to update the 2011 recommendations for the prevention and treatment of anticipatory nausea and vomiting in children and adults receiving chemotherapy. METHODS: The original systematic literature search was updated. Randomized studies were included in the evidence to support this guideline if they as follows: were primary studies published in a journal in full text (i.e., abstracts, letters, book chapters, and dissertations were excluded); published in English; evaluated an intervention for the prevention or treatment of anticipatory nausea and vomiting; reported the proportion of patients experiencing complete control of anticipatory nausea and vomiting consistently and; included at least ten participants per study arm for comparative studies and at least ten participants overall for noncomparative studies. RESULTS: Eighty-eight new citations were identified. Of these, nine were brought to full-text screening; none met inclusion criteria. The guideline panel continues to recommend that anticipatory nausea and vomiting are best prevented through optimization of acute and delayed phase chemotherapy-induced nausea and vomiting control. Benzodiazepines and behavioral therapies, in particular progressive muscle relaxation training, systematic desensitization and hypnosis, continue to be recommended for the treatment of anticipatory nausea and vomiting. CONCLUSIONS: No new information regarding interventions aimed at treating or preventing ANV that met criteria for inclusion in this systematic review was identified. The 2015 MASCC recommendations affirm the content of the 2009 MASCC recommendations for the prevention and treatment of anticipatory nausea and vomiting.
Entities:
Keywords:
Adults; Anticipatory nausea; Anticipatory vomiting; Children; Supportive care
Authors: L Lee Dupuis; Paula D Robinson; Sabrina Boodhan; Mark Holdsworth; Carol Portwine; Paul Gibson; Robert Phillips; Cathy Maan; Nancy Stefin; Lillian Sung Journal: Pediatr Blood Cancer Date: 2014-04-17 Impact factor: 3.167
Authors: Charles Kamen; Mohamedtaki A Tejani; Kavita Chandwani; Michelle Janelsins; Anita R Peoples; Joseph A Roscoe; Gary R Morrow Journal: Eur J Pharmacol Date: 2013-10-21 Impact factor: 4.432
Authors: G Marchioro; G Azzarello; F Viviani; F Barbato; M Pavanetto; F Rosetti; G L Pappagallo; O Vinante Journal: Oncology Date: 2000-08 Impact factor: 2.935
Authors: Alexander Molassiotis; Matti Aapro; Mario Dicato; Pere Gascon; Sylvia A Novoa; Nicolas Isambert; Thomas A Burke; Anna Gu; Fausto Roila Journal: J Pain Symptom Manage Date: 2013-09-24 Impact factor: 3.612
Authors: D Razavi; N Delvaux; C Farvacques; F De Brier; C Van Heer; L Kaufman; M P Derde; M Beauduin; M Piccart Journal: J Clin Oncol Date: 1993-07 Impact factor: 44.544
Authors: Tiago Nava; Marc Ansari; Jean-Hugues Dalle; Christina Diaz de Heredia; Tayfun Güngör; Eugenia Trigoso; Ulrike Falkenberg; Alice Bertaina; Brenda Gibson; Andrea Jarisch; Adriana Balduzzi; Halvard Boenig; Gergely Krivan; Kim Vettenranta; Toni Matic; Jochen Buechner; Krzysztof Kalwak; Anita Lawitschka; Akif Yesilipek; Giovanna Lucchini; Christina Peters; Dominik Turkiewicz; Riitta Niinimäki; Tamara Diesch; Thomas Lehrnbecher; Petr Sedlacek; Daphna Hutt; Arnaud Dalissier; Jacek Wachowiak; Isaac Yaniv; Jerry Stein; Koray Yalçin; Luisa Sisinni; Marco Deiana; Marianne Ifversen; Michaela Kuhlen; Roland Meisel; Shahrzad Bakhtiar; Simone Cesaro; Andre Willasch; Selim Corbacioglu; Peter Bader Journal: Bone Marrow Transplant Date: 2020-02-06 Impact factor: 5.483
Authors: L Lee Dupuis; Sadie Cook; Paula D Robinson; Deborah Tomlinson; Emily Vettese; Lillian Sung Journal: Pediatr Res Date: 2019-07-29 Impact factor: 3.756
Authors: Sylvia L Crowder; Aasha I Hoogland; Taylor L Welniak; Elizabeth A LaFranchise; Kristen M Carpenter; Daneng Li; Daniel M Rotroff; Arshiya Mariam; Christine M Pierce; Stacy M Fischer; Anita Y Kinney; Thi Dong-Binh Tran; Farzaneh Rastegari; Donna L Berry; Martine Extermann; Richard D Kim; Danielle B Tometich; Jane C Figueiredo; Jameel Muzaffar; Shahla Bari; Kea Turner; George M Weinstock; Heather S L Jim Journal: Cancer Date: 2021-10-13 Impact factor: 6.860
Authors: Jennifer Seelisch; Lillian Sung; Michael J Kelly; Jennifer L Raybin; Melissa Beauchemin; Christopher C Dvorak; Katherine Patterson Kelly; Michael L Nieder; Robert B Noll; Jennifer Thackray; Nicole J Ullrich; Sandra Cabral; L Lee Dupuis; Paula D Robinson Journal: Pediatr Blood Cancer Date: 2018-09-26 Impact factor: 3.167
Authors: E Anne Lown; Anu Banerjee; Eric Vittinghoff; Christopher C Dvorak; Wendy Hartogensis; Alexis Melton; Christina Mangurian; Hiroe Hu; Deborah Shear; Robyn Adcock; Michael Morgan; Carla Golden; Frederick M Hecht Journal: Glob Adv Health Med Date: 2019-08-14